The difficulty in timing for liver transplantation in cirrhotic patients coinfected with HIV: In search for a prognosis score

Liver Transplantation

Volumn 12, Issue 5, 2006, Pages 699-701

  Samuel, Didier ^a   Duclos Vallee, Jean Charles ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ANTIRETROVIRUS AGENT; CALCINEURIN INHIBITOR; EMTRICITABINE; HEPATITIS B SURFACE ANTIBODY; LAMIVUDINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; TENOFOVIR; VIRUS RNA;

CAUSE OF DEATH; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; GRAFT INFECTION; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION RISK; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TOXICITY; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SUPERINFECTION; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; VIRUS RESISTANCE; VIRUS TRANSMISSION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PROGNOSIS; TIME FACTORS;

EID: 33646437926     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20790     Document Type: Editorial

References (23)

1. Samuel D, Duclos Vallee JC, Teicher E, Vittecoq D. Liver transplantation in patients with HIV infection. J Hepatol 2003; 39: 3-6.
2. Jury of The International Consensus Conference on Indications of Liver Transplantation. Consensus Statement on Indications for Liver Transplantation: Paris, June 22-23, 1993. Hepatology 1994; 20: S63-S68.
3. Di Martino V, Thevenot T, Colin JF, Boyer N, Martinot M, Degos F, et al. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology 2002; 123: 1812-1822.
4. Soto B, Sanchez-Quijano A, Rodrigo L, Del Olmo JA, Garcia-Bengoechea M, Hernandez-Quero J, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. Hepatology 1997; 26: 1-5.
5. Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, et al. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 2001; 34: 1193-1199.
6. Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS 2004; 18: 2039-2045.
7. Vallet-Pichard A, Pol S. Hepatitis viruses and human immunodeficiency virus co-infection: pathogenesis and treatment. J Hepatol 2004; 41: 156-166.
8. Pineda JA, Romero-Gomez M, Dfaz-Garcia F, Giron-Gonzalez JA, Montero JL, Torre-Cisneros J, et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 2005; 41: 779-789.
9. Thio CL, Seaberg EC, Skolasky R Jr, Visscher B, Munoz A, Thomas DL, multicenter AIDS cohort study. HIV-1, hepatitis B virus and risk of liver-related mortality in the multicenter cohort study (MACS). Lancet 2002; 360: 1921-1926.
10. Prachalias AA, Pozniak A, Taylor C, Srinivasan P, Muiesan P, Wendon P, et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001; 72: 1684-1688.
11. Neff G, Bonham A, Tzakis A, Ragni M, Jayaweera D, Schiff ER, et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003; 9: 239-247.
12. Duclos-Vallée JC, Vittecoq D, Teicher E, Feray C, Roque-Afonso AM, Lombes A, et al. Hepatitis C viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV coinfected patients. J Hepatol 2005; 42: 341-349.
13. Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation 2003; 76: 370-375.
14. Fung J, Eghtesad B, Patel-Tom K, DeVera M, Chapman H, Ragni M. Liver transplantation in patients with HIV infection. Liver Transpl 2004; 10: S39-S53.
15. Terrault N, Carter JT, Carlson L, Roland ME, Stock PG. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl 2006; 12: 801-807.
16. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
17. Pache I, Duclos-Valle JC, Teicher E, Bismuth H, Castaing D, Vittecoq D, Samuel D. Indications and timing for liver transplantation in HIV-coinfected patients. Hepatology 2004; 40: 356A.
18. Ragni MV, Eghtesad B, Schlesinger KW, Dvorchik I, Fung JJ. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl 2005: 11: 1425-1430.
19. Alberti A, Clumeck N, Collins S, Gehrlich W, Lundgren J, Palu G, et al. Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol 2005: 42: 615-624.
20. Benhamou Y, Bochet M, Thibault V, Di Martino V, Caumes E, Bricaire F, et al. Long-term incidence of hepatitis B virus resistance in human immunodeficiency virus-infected patients. Hepatology 1999; 30: 1302-1306.
21. Terrault N, Roche B, Samuel D. Management of hepatitis B virus in the liver transplant setting: an European and American perspective. Liver Transpl 2005; 11: 716-732.
22. Benhamou Y, Bochet M, Thibault V, Calvez V, Fievet MH, Vig P, et al. Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open label study. Lancet 2001; 358: 718-723.
23. Benhamou Y, Tubian R, Thibault V. Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus. N Engl J Med 2003; 348: 177-178.